Previous reports have predominantly used TNF-α or VEGF, whereas we have mimicked the diabetic milieu using three of the primary drivers of DRD development in humans simultaneously: hyperglycaemia, inflammation (TNF-α and IL-1β) and VEGF. The gene discussed is TNF; the disease is dystonia 5.